Tens Of Millions of Zantac Users May Develop Cancer

Plaintiffs are looking for answers from private medical and scientific experts, not the FDA or Sanofi

Wednesday, October 7, 2020 - Over 15 million Americans were using the anti-heartburn and acid reflux medicine ranitidine, also known as Zantac before a cancer scare forced the FDA to recall the drug from the market in the US. Health authorities in the European Union have also pulled the product and the other day reaffirmed their decision to do so. Government and private health institutes are trying to get to the bottom of why levels of NDMA have increased over one thousand-fold when exposed to higher than normal temperatures. Others are investigating the interaction between NDMA and stomach acids when a person has consumed processed meats. Still, other investigations are underway looking at China's drug processing facilities as the possible source of the contamination. Whatever the source, it is a sure bet that it will be quite sometime before heartburn medicines like Zantac return to the market if they ever return at all. If you or a loved one have taken Zantac and have developed cancer, you should contact a Zantac Cancer Lawyer to help you file a claim for monetary damages and pain and suffering.

Sanofi, the maker of Zantac, is being investigated by the US Department of Justice for lying to regulators about what they were required to know about Zantac NDMA cancer. Tens of thousands of cancer sufferers are expected to soon file lawsuits claiming that regularly taking Zantac caused their cancer of the stomach, or bladder, esophagus, intestines, colon, prostate, and breast. Because of cancer's 10-plus year latency period, Zantac cancer plaintiffs may continue to come forward for decades. Thousands of plaintiffs have been organized around the country into smaller groups in multidistrict litigation (MDL) to avoid unnecessarily replicating scientific Zantac testimony and other repetitive administrative proceedings. Bellweather trials will be starting soon intending to establish a president that will encourage the defendant to offer a settlement rather than tie up the court system resources for years. Such a settlement was reached just yesterday when about 1000 women were offered $100 million from global health care and beauty product giant Johnson & Johson for cancer that was allegedly caused by using Johnson's Baby Powder. Multidistrict litigation is not the same as a class action lawsuit, and each plaintiff's case is tried individually.

Sanofi is accused of failing to warn its customers about elevated and potentially carcinogenic levels of NDMA in Zantac dating back over a decade. Over 100 million people could have developed one form of cancer or another as they assumed that the FDA had tested the drug and that it was safe. On the contrary, the FDA and Sanofi knew for over a decade after FDA approval that Zantac capsules contained a naturally-occurring carcinogen called NDMA. The company knew NDMA was a by-product of producing rocket fuel and also was being used by scientists to rapidly-induce cancer tumors in laboratory test animals. The FDA determined, however, that NDMA consumed at low levels of 96 nanograms per capsule or less was acceptable. In 2019, online drug testing pharmacy Valisure found levels of NDMA thousands of times greater and immediately notified Sanofi and the FDA by way of a citizen's petition.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.